Brief: Blue Vision Q2 operating loss narrows to DKK 481,000
July 15 (Reuters) - Blue Vision A/S BLVIS.CO :
* Q2 operating loss 481,000 Danish crowns ($70,910) versus loss 761,000 crowns year ago
* Q2 revenue 0 crowns versus 0 crowns year ago
* Parent company 2015 profit outlook remains unchanged at pre-tax profit of 2.0 million
crowns
Source text for Eikon: ID:nCSE5W2J
Further company coverage: BLVIS.CO
($1 = 6.7832 Danish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations